Diabeloop: Launch of a Multi-Country Clinical Study in Adolescents and Young Adults With T1D BERLIN, Feb. 23, 2023 (GLOBE NEWSWIRE) -- At the International Conference on Advanced Technologies & Treatments for Diabetes, Diabeloop, a leader in Automated Insulin Delivery technology,...

Drug Eluting Stent Market is estimated to be US$ 14.02 billion by 2032 with a CAGR of 6.5% during the forecast period 2032 - By PMI Covina, Oct. 19, 2022 (GLOBE NEWSWIRE) -- Drug Eluting Stent Market accounted for US$ 7.5 billion in 2022 and is estimated to be US$ 14.02 billion by 2032 and is anticipated to register a CAGR of...

Terumo Corporation and Diabeloop SA Enter Into Comprehensive Strategic Partnership Agreement to Expand Their Diabetes Care Offerings TOKYO & PARIS, Nov. 17, 2021 (GLOBE NEWSWIRE) -- Terumo Corporation, a global leader in medical technology, and the French company Diabeloop, a pioneer in therapeutic AI, announced today that...